by James Hataway
Biao He is a professor of infectious diseases in the University of Georgia College of Veterinary Medicine and a Georgia Research Alliance distinguished investigator. He and others at UGA are working on a rabies vaccine and have successfully tested a new treatment on mice that cures the disease even after the virus has spread to the brain. Credit: Paul Efland/University of Georgia
Successfully treating rabies can be a race against the clock. Those who suffer a bite from a rabid animal have a brief window of time to seek medical help before the virus takes root in the central nervous system, at which point the disease is almost invariably fatal.
Now, researchers at the University of Georgia have successfully tested a new treatment on mice that cures the disease even after the virus has spread to the brain. They published their findings recently in the Journal of Virology.
"Basically, the best way to deal with rabies right now is simple: Don't get rabies," said study co-author Biao He, a professor of infectious diseases in the UGA College of Veterinary Medicine. "We have vaccines that can prevent the disease, and we use the same vaccine as a kind of treatment after a bite, but it only works if the virus hasn't progressed too far.
"Our team has developed a new vaccine that rescues mice much longer after infection than what was traditionally thought possible."
In their mouse experiments, the animals were exposed to a strain of the rabies virus that generally reaches the brain of infected mice within three days. By day six, mice begin to exhibit the telltale physical symptoms that indicate the infection has become fatal.
However, 50 percent of mice treated with the new vaccine were saved, even after the onset of physical symptoms on day six.
"This is the most effective treatment we have seen reported in the scientific literature," He said. "If we can improve these results and translate them to humans, we may have found one of the first useful treatments for advanced rabies infection."
He and his colleagues developed their vaccine by inserting a protein from the rabies virus into another virus known as parainfluenza virus 5, or PIV5, which is thought to contribute to upper respiratory infections in dogs but is completely harmless to humans.
PIV5 acts as a delivery vehicle that carries the rabies protein to the immune system so it may create the antibodies necessary to fight off the virus.
"This is only the beginning of our work," He said. "While these preliminary results are very exciting, we are confident that we can combine this new vaccine with other therapies to boost survival rates even higher and rescue animals even when symptoms are severe."
Apart from being very effective in saving the infected mice, the researchers emphasized that their vaccine is much safer when compared to the best current treatment in mice, which uses a weakened version of the rabies virus.
"It doesn't matter how we weaken the current vaccine, the virus inside it is still rabies," said study co-author Zhen Fu, a professor of pathology in the college. "That is not a concern with our PIV5 vaccine."
The researchers will continue to perfect their vaccine's design and hope to move into more advanced animal trials soon.
"There is an urgent need in many parts of the world for a better rabies treatment, and we think this technology may serve as an excellent platform," He said. "Ultimately, we just want to try to save more lives."
Explore further: Study finds rabies booster defends pets with out-of-date vaccination against the disease
More information: Journal of Virology, http://ift.tt/1BgixaR 656-14.full.pdf+html
Medical Xpress on facebook
Related Stories
New rabies vaccine could reduce cost, risk
Feb 21, 2013
(Medical Xpress)—Researchers at the University of Georgia used a common dog disease-canine parainfluenza-to build a new vaccine to protect humans and animals from the rabies virus. Developers hope the new treatment will ...
Study finds rabies booster defends pets with out-of-date vaccination against the disease
4 hours ago
A new study by Kansas State University veterinary diagnosticians finds that pets with out-of-date rabies vaccinations are very unlikely to develop the fatal disease if given a rabies booster immediately after exposure to ...
Chikungunya virus shuts down infected cells
Dec 17, 2014
Researchers from Wageningen University, part of Wageningen UR, in collaboration with colleagues from Leiden University and a research team in Australia, have revealed how chikungunya virus blocks essential ...
Man's best friend: Common canine virus may lead to new vaccines for deadly human diseases
Nov 27, 2012
Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.
Researchers find new method to combat common childhood illness
Apr 18, 2014
Almost all children are infected with respiratory syncytial virus by the time they are two. Most recover quickly from cold-like symptoms. But for others, RSV can cause serious lung infections, such as bronchiolitis ...
Recommended for you
Pre-op back pain, pain sensitivity predict outcomes
4 minutes ago
(HealthDay)—Preoperative back pain and individual pain sensitivity can predict postoperative pain following lumbar surgery, according to a study published in the December issue of Pain Medicine.
Liberia: Only five people being treated for Ebola in country
2 hours ago
Liberia said Monday that there are currently only five confirmed cases of Ebola in the entire country—a dramatic turnaround in the West African nation where the virus has taken its deadliest toll.
Nocturnal leg cramps more common in summer
3 hours ago
Painful nocturnal leg cramps are about twice as common during summer than in winter, found a new study in CMAJ (Canadian Medical Association Journal).
Senegal opens Guinea border as Ebola recedes
4 hours ago
Senegal reopened its land border with Guinea on Monday, pointing to the "significant efforts" of its neighbour in fighting an Ebola outbreak that has claimed thousands of lives.
The treatment of parasitic skin disease Leishmaniasis in Suriname
6 hours ago
Almost twelve million people world-wide are infected by Leishmaniasis. This disease can cause large, open wounds all over the body. However, not many people go – in time – to the doctor, while it is important to be treated ...
How your friends might help you avoid flu
6 hours ago
A study of social networks has yielded clues about how best to improve vaccination rates for influenza.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
by James Hataway
Biao He is a professor of infectious diseases in the University of Georgia College of Veterinary Medicine and a Georgia Research Alliance distinguished investigator. He and others at UGA are working on a rabies vaccine and have successfully tested a new treatment on mice that cures the disease even after the virus has spread to the brain. Credit: Paul Efland/University of Georgia
Successfully treating rabies can be a race against the clock. Those who suffer a bite from a rabid animal have a brief window of time to seek medical help before the virus takes root in the central nervous system, at which point the disease is almost invariably fatal.
Now, researchers at the University of Georgia have successfully tested a new treatment on mice that cures the disease even after the virus has spread to the brain. They published their findings recently in the Journal of Virology.
"Basically, the best way to deal with rabies right now is simple: Don't get rabies," said study co-author Biao He, a professor of infectious diseases in the UGA College of Veterinary Medicine. "We have vaccines that can prevent the disease, and we use the same vaccine as a kind of treatment after a bite, but it only works if the virus hasn't progressed too far.
"Our team has developed a new vaccine that rescues mice much longer after infection than what was traditionally thought possible."
In their mouse experiments, the animals were exposed to a strain of the rabies virus that generally reaches the brain of infected mice within three days. By day six, mice begin to exhibit the telltale physical symptoms that indicate the infection has become fatal.
However, 50 percent of mice treated with the new vaccine were saved, even after the onset of physical symptoms on day six.
"This is the most effective treatment we have seen reported in the scientific literature," He said. "If we can improve these results and translate them to humans, we may have found one of the first useful treatments for advanced rabies infection."
He and his colleagues developed their vaccine by inserting a protein from the rabies virus into another virus known as parainfluenza virus 5, or PIV5, which is thought to contribute to upper respiratory infections in dogs but is completely harmless to humans.
PIV5 acts as a delivery vehicle that carries the rabies protein to the immune system so it may create the antibodies necessary to fight off the virus.
"This is only the beginning of our work," He said. "While these preliminary results are very exciting, we are confident that we can combine this new vaccine with other therapies to boost survival rates even higher and rescue animals even when symptoms are severe."
Apart from being very effective in saving the infected mice, the researchers emphasized that their vaccine is much safer when compared to the best current treatment in mice, which uses a weakened version of the rabies virus.
"It doesn't matter how we weaken the current vaccine, the virus inside it is still rabies," said study co-author Zhen Fu, a professor of pathology in the college. "That is not a concern with our PIV5 vaccine."
The researchers will continue to perfect their vaccine's design and hope to move into more advanced animal trials soon.
"There is an urgent need in many parts of the world for a better rabies treatment, and we think this technology may serve as an excellent platform," He said. "Ultimately, we just want to try to save more lives."
Explore further: Study finds rabies booster defends pets with out-of-date vaccination against the disease
More information: Journal of Virology, http://ift.tt/1BgixaR 656-14.full.pdf+html
Medical Xpress on facebook
Related Stories
New rabies vaccine could reduce cost, risk
Feb 21, 2013
(Medical Xpress)—Researchers at the University of Georgia used a common dog disease-canine parainfluenza-to build a new vaccine to protect humans and animals from the rabies virus. Developers hope the new treatment will ...
Study finds rabies booster defends pets with out-of-date vaccination against the disease
4 hours ago
A new study by Kansas State University veterinary diagnosticians finds that pets with out-of-date rabies vaccinations are very unlikely to develop the fatal disease if given a rabies booster immediately after exposure to ...
Chikungunya virus shuts down infected cells
Dec 17, 2014
Researchers from Wageningen University, part of Wageningen UR, in collaboration with colleagues from Leiden University and a research team in Australia, have revealed how chikungunya virus blocks essential ...
Man's best friend: Common canine virus may lead to new vaccines for deadly human diseases
Nov 27, 2012
Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.
Researchers find new method to combat common childhood illness
Apr 18, 2014
Almost all children are infected with respiratory syncytial virus by the time they are two. Most recover quickly from cold-like symptoms. But for others, RSV can cause serious lung infections, such as bronchiolitis ...
Recommended for you
Pre-op back pain, pain sensitivity predict outcomes
4 minutes ago
(HealthDay)—Preoperative back pain and individual pain sensitivity can predict postoperative pain following lumbar surgery, according to a study published in the December issue of Pain Medicine.
Liberia: Only five people being treated for Ebola in country
2 hours ago
Liberia said Monday that there are currently only five confirmed cases of Ebola in the entire country—a dramatic turnaround in the West African nation where the virus has taken its deadliest toll.
Nocturnal leg cramps more common in summer
3 hours ago
Painful nocturnal leg cramps are about twice as common during summer than in winter, found a new study in CMAJ (Canadian Medical Association Journal).
Senegal opens Guinea border as Ebola recedes
4 hours ago
Senegal reopened its land border with Guinea on Monday, pointing to the "significant efforts" of its neighbour in fighting an Ebola outbreak that has claimed thousands of lives.
The treatment of parasitic skin disease Leishmaniasis in Suriname
6 hours ago
Almost twelve million people world-wide are infected by Leishmaniasis. This disease can cause large, open wounds all over the body. However, not many people go – in time – to the doctor, while it is important to be treated ...
How your friends might help you avoid flu
6 hours ago
A study of social networks has yielded clues about how best to improve vaccination rates for influenza.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment